A clinical formulation indicated for Antifungals. This topical preparation promotes dermal recovery by disrupting the fungal growth processes that cause skin irritation.
Indicated to address fungal skin infections by targeting cell membrane synthesis to support skin healing and alleviate itching and scaling in adult patients.
Mechanism of Action
Luliconazole inhibits the production of ergosterol, a vital component of the fungal cell membrane. Without this substance, the fungal cells become unstable and die, clearing the infection from the skin.
Route of Administration
Topical
Onset Time
1 week
Duration
24 hours
Contraindications
Hypersensitivity to luliconazole
Severe Adverse Events
Severe allergic dermatitis, Blistering at application site, Severe skin swelling
Common Side Effects
Mild skin irritation
Uncommon Side Effects
Application site itching, Skin burning, Redness, Stinging
Pregnancy Safety Warnings
Use only if clearly needed.
Age Restrictions
Approved for patients 12 years and older (Athlete's foot).
Information for Luzu 1% is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
